RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Bicycle Therapeutics Market capitalization 2024

Bicycle Therapeutics Market capitalization

819.69 M USD

Bicycle Therapeutics Dividend yield

Ticker

BCYC

ISIN

US0887861088

WKN

A2PKZC

In 2024, Bicycle Therapeutics's market cap stood at 819.69 M USD, a -10.07% increase from the 911.45 M USD market cap in the previous year.

The Bicycle Therapeutics Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e714.37-229.38
2028e358.81--46.52
2027e130.1--193.92
2026e44.15--226.63
2025e29.47--221.85
2024e38.74--192.47
202326.98--180.66
202214.46--112.72
202111.7--66.82
202010.39--51.01
201913.8--30.61
20187.14--21.85
20172.06--16.26
2016---13.55

Bicycle Therapeutics Aktienanalyse

What does Bicycle Therapeutics do?

Bicycle Therapeutics PLC is a British biotechnology company specializing in the development of innovative drugs for the treatment of cancer and other diseases. The company was founded in 2009 by Sir Greg Winter, John McCafferty, and Sir Tom Blundell. They discovered a new class of molecules called Bicycles, which are small enough to penetrate the human body but large enough to selectively bind to cells and tissues and influence their biological functions. Bicycles are based on a technology called phage display, which allows for the targeted identification and isolation of molecules with specific properties. The business model of Bicycle Therapeutics revolves around using Bicycles as drug candidates for the development of new medications. The company collaborates with leading pharmaceutical and biotechnology companies to jointly develop new therapies, focusing primarily on cancer treatment due to the high demand for targeted therapies in this field. Bicycle Therapeutics has various divisions dedicated to the development of drugs for specific types of cancer. Immunoncology is one such division, which focuses on mobilizing the body's immune system to fight cancer. Another division, Targeted Payloads, concentrates on developing medications that specifically attack and destroy cancer cells. The company offers a range of products developed based on Bicycles, including therapeutic antibodies that selectively target and destroy cancer cells, as well as diagnostics for the early detection and diagnosis of cancer. One example of Bicycle Therapeutics' product is BT1718, a therapeutic antibody that specifically targets the membrane protein 5 (MP5). MP5 is expressed on the surface of various cancer cells and is therefore a promising target for cancer therapy. BT1718 has shown promising results in clinical studies involving patients with various types of cancer. Another example is BT5528, a targeted payload that targets the EphA2 receptor. EphA2 is expressed on the surface of different cancer cells and plays a crucial role in tumor progression. BT5528 is a molecule that specifically binds to EphA2 and releases a payload that attacks and destroys cancer cells. The product is currently in clinical development. Overall, Bicycle Therapeutics is a promising biotechnology company specializing in the development of innovative drugs for the treatment of cancer and other diseases. The company has a unique technology platform and collaborates with leading pharmaceutical and biotechnology companies to develop new therapies. With products like BT1718 and BT5528, Bicycle Therapeutics has already achieved promising results and remains an important player in the field of cancer therapy. Bicycle Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Bicycle Therapeutics's Market Capitalization

Bicycle Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Bicycle Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Bicycle Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Bicycle Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Bicycle Therapeutics Stock

What is the current Bicycle Therapeutics market capitalization?

The current market capitalization of Bicycle Therapeutics is 819.69 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Bicycle Therapeutics.

How has the market capitalization of Bicycle Therapeutics developed in recent years?

The market capitalization of Bicycle Therapeutics has increased/decreased by -10.07% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Bicycle Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Bicycle Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Bicycle Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Bicycle Therapeutics pay?

Over the past 12 months, Bicycle Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bicycle Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Bicycle Therapeutics?

The current dividend yield of Bicycle Therapeutics is .

When does Bicycle Therapeutics pay dividends?

Bicycle Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bicycle Therapeutics?

Bicycle Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Bicycle Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bicycle Therapeutics located?

Bicycle Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bicycle Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bicycle Therapeutics from 5/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/26/2024.

When did Bicycle Therapeutics pay the last dividend?

The last dividend was paid out on 5/26/2024.

What was the dividend of Bicycle Therapeutics in the year 2023?

In the year 2023, Bicycle Therapeutics distributed 0 USD as dividends.

In which currency does Bicycle Therapeutics pay out the dividend?

The dividends of Bicycle Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bicycle Therapeutics

Our stock analysis for Bicycle Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bicycle Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.